CAPS and hepatocellular carcinoma: We previously identified CAPS1 as a promising serum biomarker for HCC diagnosis by magnetic bead-based (MB) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) [11].